Use of Stem Cell Markers in Dissociated Mammary Populations

  • Dawne N. Shelton
  • Rodrigo Fernandez-Gonzalez
  • Irineu Illa-Bochaca
  • Carlos Ortiz-de-Solorzano
  • Mary Helen Barcellos-HoffEmail author
  • Bryan E. Welm
Part of the Methods in Molecular Biology™ book series (MIMB, volume 621)


The regenerative potential of mammary epithelium facilitates assessment of the “stemness” of any epithelial subpopulation in transplantation assays. Thus, mammary tissue can be dissociated into single cells, stained for cell surface markers of interest and classified using fluorescence-activated cell sorting. The selected cells can then be transplanted into epithelium-devoided fat pads from recipient hosts. Recent publications have described markers that enrich for mammary repopulating potential. Here, we describe the materials and methods necessary to sort cells according to these markers. This approach can be used interchangeably with other cell surface markers with slight variation to the protocol.

Key words

Mammary primary culture CD24 CD49f Mammary repopulating unit 



This work was supported by a predoctoral fellowship to RFG from the Department of Defense Breast Cancer Research Program (DAMD 17-03-1-0594), grants from the same institution to COS (DAMD 17-00-1-0227 and DAMD 17-00-1-0306), a grant to BEW from the National Cancer Institute (CA 8424306), and a grant to MHBH funded by the National Institute of Environmental Health Sciences and the National Cancer Institute (U01ES012801).


  1. 1.
    Smith GH (1996) Experimental mammary epithelial morphogenesis in an in vivo model: evidence for distinct cellular progenitors of the ductal and lobular phenotype. Breast Cancer Res Treat 39:21–31CrossRefPubMedGoogle Scholar
  2. 2.
    Shackleton M, Vaillant F, Simpson KJ, Stingl J, Smyth GK, Asselin-Labat ML, Wu L, Lindeman GJ, Visvader JE (2006) Generation of a functional mammary gland from a single stem cell. Nature 439:84–88CrossRefPubMedGoogle Scholar
  3. 3.
    Stingl J, Eirew P, Ricketson I, Shackleton M, Vaillant F, Choi D, Li HYI, Eaves CJ (2006) Purification and unique properties of mammary epithelial stem cells. Nature 439:993–997PubMedGoogle Scholar
  4. 4.
    Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100:3983–3988CrossRefPubMedGoogle Scholar
  5. 5.
    Asselin-Labat ML, Shackleton M, Stingl J, Vaillant F, Forrest NC, Eaves CJ, Visvader JE, Lindeman GJ (2006) Steroid hormone receptor status of mouse mammary stem cells. J Natl Cancer Inst 98:1011–1014CrossRefPubMedGoogle Scholar
  6. 6.
    Asselin-Labat ML, Sutherland KD, Barker H, Thomas R, Shackleton M, Forrest NC, Hartley L, Robb L, Grosveld FG, van der Wees J, Lindeman GJ, Visvader JE (2007) Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat Cell Biol 9:201–209CrossRefPubMedGoogle Scholar
  7. 7.
    Sleeman KE, Kendrick H, Ashworth A, Isacke CM, Smalley MJ (2006) CD24 staining of mouse mammary gland cells defines luminal epithelial, myoepithelial/basal and non-epithelial cells. Breast Cancer Res 8:R7CrossRefPubMedGoogle Scholar
  8. 8.
    Sleeman KE, Kendrick H, Robertson D, Isacke CM, Ashworth A, Smalley MJ (2007) Dissociation of estrogen receptor expression and in vivo stem cell activity in the mammary gland. J Cell Biol 176:19–26CrossRefPubMedGoogle Scholar
  9. 9.
    Stingl J, Eaves CJ, Zandieh I, Emerman JT (2001) Characterization of bipotent mammary epithelial progenitor cells in normal adult human breast tissue. Breast Cancer Res Treat 67:93–109CrossRefPubMedGoogle Scholar
  10. 10.
    Welm BE, Tepera SB, Venezia T, Graubert TA, Rosen JM, Goodell MA (2002) Sca-1(pos) cells in the mouse mammary gland represent an enriched progenitor cell population. Dev Biol 245:42–56CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Dawne N. Shelton
    • 1
  • Rodrigo Fernandez-Gonzalez
    • 2
  • Irineu Illa-Bochaca
    • 3
  • Carlos Ortiz-de-Solorzano
    • 4
  • Mary Helen Barcellos-Hoff
    • 3
    Email author
  • Bryan E. Welm
    • 1
  1. 1.Department of SurgeryUniversity of Utah, Huntsman Cancer InstituteSalt Lake CityUSA
  2. 2.Development Biology ProgramSloan-Kettering, Institute, Memorial Sloan-Kettering Cancer CenterNew YorkUSA
  3. 3.Langone School of MedicineNew York UniversityNew YorkUSA
  4. 4.Morphology and Imaging Group and Cancer Imaging Laboratory, Center for Applied Medical ResearchUniversity of NavarrePamplonaSpain

Personalised recommendations